1102 companies

Strategy

Market Cap: US$97.2b

Operates as a bitcoin treasury company in the United States, Europe, the Middle East, Africa, and internationally.

MSTR

US$341.62

7D

-0.1%

1Y

173.6%

Atlassian

Market Cap: US$46.6b

Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.

TEAM

US$172.68

7D

5.1%

1Y

5.4%

Duolingo

Market Cap: US$13.6b

Operates as a mobile learning platform in the United States, the United Kingdom, and internationally.

DUOL

US$289.98

7D

-8.2%

1Y

40.5%

QXO

Market Cap: US$13.6b

Distributes roofing, waterproofing, and other building products in the United States.

QXO

US$21.13

7D

1.0%

1Y

59.0%

BioMarin Pharmaceutical

Market Cap: US$11.2b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

BMRN

US$59.09

7D

2.9%

1Y

-35.5%

Aurora Innovation

Market Cap: US$10.4b

Operates as a self-driving technology company in the United States.

AUR

US$5.80

7D

-0.3%

1Y

36.2%

U-Haul Holding

Market Cap: US$10.3b

Operates as a do-it-yourself moving and storage operator for household and commercial goods in the United States and Canada.

UHAL

US$57.09

7D

0.05%

1Y

-18.4%

monday.com

Market Cap: US$9.9b

Develops software applications in the United States, Europe, the Middle East, Africa, the United Kingdom, and internationally.

MNDY

US$187.34

7D

6.5%

1Y

-25.3%

Chime Financial

Market Cap: US$9.8b

A financial technology company, provides digital consumer banking and payment solutions.

CHYM

US$24.72

7D

-8.8%

1Y

n/a

Klaviyo

Market Cap: US$9.7b

A technology company, provides a software-as-a-service platform in the United States, other Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

KVYO

US$30.75

7D

-2.5%

1Y

1.1%

Moderna

Market Cap: US$9.4b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

MRNA

US$24.19

7D

-2.2%

1Y

-66.8%

Liberty Broadband

Market Cap: US$8.7b

Engages in a range of communications businesses in the United States.

LBRD.K

US$60.66

7D

-0.8%

1Y

-1.5%

VinFast Auto

Market Cap: US$8.0b

Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.

VFS

US$3.36

7D

-2.9%

1Y

-4.3%

Wix.com

Market Cap: US$7.9b

Operates a cloud-based web development platform for registered users and creators worldwide.

WIX

US$137.33

7D

4.3%

1Y

-12.8%

Corcept Therapeutics

Market Cap: US$7.3b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

CORT

US$71.38

7D

2.6%

1Y

108.3%

Revolution Medicines

Market Cap: US$7.1b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

RVMD

US$39.53

7D

6.0%

1Y

-4.9%

Legend Biotech

Market Cap: US$6.4b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

LEGN

US$34.22

7D

-2.5%

1Y

-40.3%

Clearwater Analytics Holdings

Market Cap: US$6.2b

Develops and provides a Software-as-a-Service (SaaS) solution for automated investment data aggregation, reconciliation, accounting, and reporting services to insurers, investment managers, corporations, institutional investors, and government entities in the United States and internationally.

CWAN

US$20.19

7D

1.1%

1Y

-16.2%

Caesars Entertainment

Market Cap: US$5.6b

Operates as a gaming and hospitality company.

CZR

US$25.89

7D

-1.0%

1Y

-28.7%

Nuvalent

Market Cap: US$5.5b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

NUVL

US$76.90

7D

1.0%

1Y

-9.1%

CRISPR Therapeutics

Market Cap: US$4.7b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

CRSP

US$52.66

7D

-4.0%

1Y

15.7%

ADMA Biologics

Market Cap: US$4.1b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ADMA

US$17.20

7D

0.6%

1Y

3.8%

Vaxcyte

Market Cap: US$4.0b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

PCVX

US$31.56

7D

4.3%

1Y

-71.3%

Qfin Holdings

Market Cap: US$3.9b

Qfin Holdings, Inc., together with its subsidiaries, operate AI- driven credit-tech platform under the Qifu Jietiao brand in the People’s Republic of China.

QFIN

US$29.61

7D

-2.6%

1Y

15.7%

Arcellx

Market Cap: US$3.8b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

ACLX

US$69.75

7D

-0.2%

1Y

5.5%

Freshworks

Market Cap: US$3.8b

A software development company, provides software-as-a-service products in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally.

FRSH

US$13.16

7D

-3.3%

1Y

13.9%

Remitly Global

Market Cap: US$3.8b

Engages in the provision of digital financial services in the United States, Canada, and internationally.

RELY

US$18.92

7D

4.2%

1Y

40.8%

Globalstar

Market Cap: US$3.8b

Provides mobile satellite services in the United States, Canada, Europe, Central and South America, and internationally.

GSAT

US$30.35

7D

8.5%

1Y

58.1%

Akero Therapeutics

Market Cap: US$3.7b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

AKRO

US$45.44

7D

-5.6%

1Y

74.8%

Lantheus Holdings

Market Cap: US$3.7b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

LNTH

US$55.29

7D

-0.7%

1Y

-47.6%

Metsera

Market Cap: US$3.7b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

MTSR

US$36.21

7D

9.1%

1Y

n/a

Zai Lab

Market Cap: US$3.7b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

ZLAB

US$33.34

7D

-2.7%

1Y

72.3%

Soleno Therapeutics

Market Cap: US$3.6b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

SLNO

US$67.22

7D

-3.4%

1Y

42.2%

Chagee Holdings

Market Cap: US$3.5b

Through its subsidiaries, owns, operates, and franchises teahouses under the CHAGEE brand name in the People’s Republic of China and internationally.

CHA

US$18.50

7D

-19.6%

1Y

n/a

SharpLink Gaming

Market Cap: US$3.1b

An online performance marketing company, delivers fan activation solutions to its sportsbook and casino partners.

SBET

US$16.98

7D

-14.8%

1Y

96.1%

Scholar Rock Holding

Market Cap: US$3.1b

A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.

SRRK

US$33.12

7D

-2.0%

1Y

264.0%

Page 1 of 31